The impact of community-wide, mass drug administration on aggregation of soil-transmitted helminth infection in human host populations.

Parasites & Vectors
Marleen WerkmanRoy Anderson

Abstract

Soil-transmitted helminths (STH) are intestinal parasites estimated to infect over 1.5 billion people. Current treatment programmes are aimed at morbidity control through school-based deworming programmes (targeting school-aged children, SAC) and treating women of reproductive age (WRA), as these two groups are believed to record the highest morbidity. More recently, however, the potential for interrupting transmission by treating entire communities has been receiving greater emphasis and the feasibility of such programmes are now under investigation in randomised clinical trials through the Bill & Melinda Gates Foundation funded DeWorm3 studies. Helminth parasites are known to be highly aggregated within human populations, with a small minority of individuals harbouring most worms. Empirical evidence from the TUMIKIA project in Kenya suggests that aggregation may increase significantly after anthelminthic treatment. A stochastic, age-structured, individual-based simulation model of parasite transmission is employed to better understand the factors that might induce this pattern. A simple probabilistic model based on compounded negative binomial distributions caused by age-dependencies in both treatment coverage and exposure to...Continue Reading

References

Jan 1, 1992·Transactions of the Royal Society of Tropical Medicine and Hygiene·M BradleyG F Medley
Nov 1, 1991·Transactions of the Royal Society of Tropical Medicine and Hygiene·H L Guyatt, D A Bundy
Jan 1, 1985·Advances in Parasitology·R M Anderson, R M May
Mar 4, 2000·Transactions of the Royal Society of Tropical Medicine and Hygiene·A HallL Rahman
Jun 20, 2000·Parasitology Today·A P PlaisierJ D Habbema
Dec 1, 1979·Kisaengch'unghak chapchi. The Korean journal of parasitology·Byong Seol SeoJong Yil Chai
Apr 24, 2008·JAMA : the Journal of the American Medical Association·Jennifer Keiser, Jürg Utzinger
Mar 8, 2013·PLoS Neglected Tropical Diseases·Roy M AndersonT Deirdre Hollingsworth
Jan 23, 2014·Parasites & Vectors·Rachel L PullanSimon J Brooker
May 14, 2014·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Roy AndersonT Deirdre Hollingsworth
Jun 12, 2014·Parasites & Vectors·James E TruscottRoy M Anderson
Jul 25, 2014·PLoS Neglected Tropical Diseases·Peter J HotezMohsen Naghavi
Mar 11, 2017·Epidemics·Louise DysonT Déirdre Hollingsworth
Apr 21, 2017·PLoS Neglected Tropical Diseases·Peter Mark JourdanJudd L Walson
Jul 13, 2017·Current Opinion in Infectious Diseases·Kristjana H ÁsbjörnsdóttirJudd L Walson
Jun 4, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sam H FarrellRoy M Anderson

❮ Previous
Next ❯

Citations

Aug 23, 2021·The Lancet Infectious Diseases·Roy M Anderson

❮ Previous
Next ❯

Methods Mentioned

BETA
MDA

Software Mentioned

STARWORM

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.